Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 53

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 53
---
 rights:

Voting Rights. Each share of our
common stock entitles its holder to one vote per share on all matters to be voted or consented upon by the stockholders.

Dividend Rights. Subject to limitations
under Delaware law, holders of our common stock are entitled to receive ratably such dividends or other distributions, if any, as may
be declared by our Board out of funds legally available therefor.

Liquidation Rights. In the event
of liquidation, dissolution or winding up of our business, the holders of our common stock are entitled to share ratably in the assets
available for distribution after the payment of all of our debts and other liabilities.

Other Matters. The holders of our
common stock have no subscription, redemption or conversion privileges; in addition, such common stock does not entitle its holders to
pre-emptive rights. All of the outstanding shares of our common stock are fully paid and non-assessable.

Section 203 of the Delaware General Corporation Law

We are subject to the provisions of Section 203
of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under certain circumstances, from engaging
in a “business combination” with:

| ● | a stockholder who owns 15%                                                                
 or more of our outstanding voting stock (otherwise known as an “interested stockholder”); |

| ● | an affiliate of an interested 
 stockholder; or               |

| ● | an associate of an interested                                                                          
 stockholder, for three years following the date that the stockholder became an interested stockholder. |

<div align='center'>27</div>

A “business combination” includes
a merger or sale of more than 10% of our assets. However, the above provisions of Section 203 do not apply if:

| ● | our Board approves the transaction                                                              
 that made the stockholder an “interested stockholder,” prior to the date of the transaction; or |

| ● | after the completion of the                                                                                                              
 transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of our voting stock 
 outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock.                               |

Potential Effects of Authorized but Unissued Stock

Our shares of common and preferred stock are available
for future issuance without stockholder approval. We may utilize these additional shares for a variety of corporate purposes, including
future public offerings to raise additional capital, to facilitate corporate acquisitions